Tuesday - January 13, 2026

Category Archives: Business

ADM Endeavors (OTCQB: ADMQ) Reports $5.3M Revenue, Expands Operations Supporting 2026 Expansion Alongside EVTV, PASW, BMXI, UP, PNPNF

ADM Endeavors (OTCQB: ADMQ), a diversified direct marketing and value-added manufacturing company, continues to build momentum as its wholly owned subsidiary Just Right Products, Inc., delivers consistent revenue growth, expands into new markets, and significantly scales its operational facility footprint. … Continue reading →

Global Neurofibromatosis Type 2 Pipeline Expands With 5+ Companies Advancing 5+ Therapies, Reveals DelveInsight’s Clinical and Developmental Analysis

Neurofibromatosis Type 2 Pipeline Leading Neurofibromatosis Type 2 Companies include Recursion Pharmaceuticals, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics, AstraZeneca, Fosun Pharmaceutical, NFlection Therapeutics, and several other innovators. The global Neurofibromatosis Type 2 (NF2) therapeutic pipeline is witnessing steady expansion, driven … Continue reading →

Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Chronic Myeloid Leukaemia Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Myeloid Leukaemia pipeline landscape. It covers the Chronic Myeloid Leukemia pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Tendinopathy Market Size in the 7MM is Project to Grow with a Significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Tendonitis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Tendonitis, historical and forecasted epidemiology as well as the Tendonitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and … Continue reading →

Bipolar Disorder Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Bipolar Disorder Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Bipolar Disorder pipeline landscape. It covers the Bipolar Disorder Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Pre-Eclampsia Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Pre-Eclampsia Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pre-Eclampsia pipeline landscape. It covers the Pre-Eclampsia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Pre-Eclampsia Pipeline Therapeutics … Continue reading →

Nipocalimab Market Size Forecast and Emerging Insights Signal Strong Growth Outlook Through 2034, estimates DelveInsight

Nipocalimab Market Nipocalimab Overview in approved indications like Myasthenia gravis; as well as potential indications like Fetal erythroblastosis, Neonatal alloimmune thrombocytopenia, Sjogren’s syndrome, Systemic lupus erythematosus and others. The Nipocalimab market is entering a pivotal growth phase, driven by recent … Continue reading →